Air Canada
AC
BCE Inc
BCE
Global Compliance Applications Corp
APP
4
National Bank of Canada
NA
5
Enbridge Inc
ENB
CA Stock MarketDetailed Quotes
DTC Defence Therapeutics Inc
- 1.260
- +0.270+27.27%
15min DelayMarket Closed Feb 26 15:59 ET
60.04MMarket Cap-14.00P/E (TTM)
1.260High1.150Low79.79KVolume1.150Open0.990Pre Close96.65KTurnover2.05052wk High0.17%Turnover Ratio47.65MShares0.48052wk Low-0.09EPS TTM57.85MFloat Cap8.150Historical HighLossP/E (Static)45.91MShs Float0.480Historical Low-0.3EPS LYR11.11%Amplitude--Dividend TTM-17.26P/B1Lot Size--Div YieldTTM
About Defence Therapeutics Inc Company
Defence Therapeutics Inc is engaged in the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases. The Company has one operating segment, being research and development. It operates only in Canada.
Company Profile
SymbolDTC
Company NameDefence Therapeutics Inc
Founded2017
MarketCNQ
Employees2
Fiscal Year Ends06-30
Address200 Burrard Street Suite 1680
CityVancouver
CountryCAN
Zip CodeV6C3L6
Phone+1 514 947-2272
Company Executives
- Name
- Position
- Salary
- Simon Beaudoin
- CTSO and Accum Co-Founder
- --
- Sebastien Plouffe
- CEO and Director
- --
- Joseph Meagher
- CFO and Director
- --
- Raimar Lobenberg
- Chairman of the Board
- --
- Sarkis Meterissian
- Director
- --
- Moutih Rafei
- VP Research and Development and Director
- --